
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $44.2M | -- | -- | $0.66 | -- |
07/24/2025 | Q2 | $42.6M | -- | -- | $0.68 | -- |
04/24/2025 | Q1 | $40.4M | $40.1M | $0.66 | $0.52 | $0.15 |
01/30/2025 | Q4 | $39.8M | $39.7M | $0.63 | $0.53 | $0.10 |
10/29/2024 | Q3 | $37.8M | $38.3M | $0.53 | $0.44 | $0.09 |
07/29/2024 | Q2 | $37.1M | $37.7M | $0.45 | $0.39 | $0.06 |
04/30/2024 | Q1 | $38.3M | $36.3M | $0.41 | $0.46 | -$0.05 |
02/08/2024 | Q4 | $39.5M | $38.3M | $0.62 | $0.58 | $0.04 |
10/27/2023 | Q3 | -- | -- | $0.66 | $0.61 | $0.05 |
07/28/2023 | Q2 | -- | -- | $0.64 | $0.72 | -$0.08 |
04/28/2023 | Q1 | -- | -- | $0.82 | $0.81 | $0.01 |
02/07/2023 | Q4 | -- | -- | $0.77 | $0.75 | $0.02 |
10/27/2022 | Q3 | -- | -- | $0.72 | $0.61 | $0.11 |
07/28/2022 | Q2 | -- | -- | $0.53 | $0.54 | -$0.01 |
04/28/2022 | Q1 | -- | -- | $0.57 | -- | -- |
02/04/2022 | Q4 | -- | -- | $0.73 | -- | -- |
10/27/2021 | Q3 | -- | -- | $0.64 | -- | -- |
07/23/2021 | Q2 | -- | -- | $0.59 | -- | -- |
04/23/2021 | Q1 | -- | -- | $0.68 | -- | -- |
02/05/2021 | Q4 | -- | -- | $0.64 | -- | -- |
10/23/2020 | Q3 | -- | -- | $0.48 | -- | -- |
07/24/2020 | Q2 | -- | -- | $0.41 | -- | -- |
04/24/2020 | Q1 | -- | -- | $0.47 | -- | -- |
02/07/2020 | Q4 | -- | -- | $0.47 | -- | -- |
10/25/2019 | Q3 | -- | -- | $0.46 | -- | -- |
07/26/2019 | Q2 | -- | -- | $0.51 | -- | -- |
05/03/2019 | Q1 | -- | -- | $0.57 | -- | -- |
01/15/2019 | Q4 | -- | -- | $0.45 | -- | -- |
11/02/2018 | Q3 | -- | -- | -$0.31 | -- | -- |
07/27/2018 | Q2 | -- | -- | $0.24 | -- | -- |
04/27/2018 | Q1 | -- | -- | $0.55 | -- | -- |
01/26/2018 | Q4 | -- | -- | $0.32 | -- | -- |
10/27/2017 | Q3 | -- | -- | $0.29 | -- | -- |
07/28/2017 | Q2 | -- | -- | $0.29 | -- | -- |
04/28/2017 | Q1 | -- | -- | $0.40 | -- | -- |
01/27/2017 | Q4 | -- | -- | $0.33 | -- | -- |
10/21/2016 | Q3 | -- | -- | $0.34 | -- | -- |
07/22/2016 | Q2 | -- | -- | $0.47 | -- | -- |
04/22/2016 | Q1 | -- | -- | $0.43 | -- | -- |
01/22/2016 | Q4 | -- | -- | $0.29 | -- | -- |
10/23/2015 | Q3 | -- | -- | $0.30 | -- | -- |
Civista Bancshares reported $40.1M worth of top line sales in its most recent quarter.
Civista Bancshares announced earnings per share of $0.66 which represents a beat of analyst forecast a $0.52 per share.
Civista Bancshares reported -- that represents -- per share over the last quarter.
Civista Bancshares's earnings are forecast to grow from $2.01 per share to $1.91 per share next year representing an increase of 40.88%.
Civista Bancshares's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.